Portal de Periódicos da CAPES

The sub-Saharan Africa position statement on the redefinition of fatty liver disease: From NAFLD to MAFLD

2021; Elsevier BV; Volume: 74; Issue: 5 Linguagem: Inglês

10.1016/j.jhep.2021.01.015

1600-0641

C. Wendy Spearman, Hailemichael Desalegn, Ponsiano Ocama, Yaw Asante Awuku, Olusegun Ojo, Medhat Elsahhar, Abdulmunem A. Abdo, D A Ndububa, Yasser Fouad, Musa M Borodo, Masolwa Ng’wanasayi, Reidwan Ally, Reda Elwakil,

Diet, Metabolism, and Disease

We read with great interest the landmark consensus on the redefinition of fatty liver disease by Eslam et al. This includes a shift in nomenclature from non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated fatty liver disease (MAFLD) as a more apt term, as well as the adoption of a set of simple and pertinent “positive” criteria to diagnose the disease, independent of alcohol intake or other liver diseases.1,2 These twin proposals provide a major advance in the conceptualisation of fatty liver diseases, but given the variation between different health systems, reaching a broad and global consensus is imperative.